Rolufta Ellipta is a medicine used to relieve the symptoms of chronic obstructive pulmonary disease (COPD) in adults. COPD is a long\-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing. Rolufta Ellipta is used for maintenance (regular) treatment. Rolufta Ellipta contains the active substance umeclidinium bromide.
Therapeutic Indication
Rolufta is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Therapeutic Area (MeSH)
ATC Code
R03BB07
ATC Item
N/A
Pharmacotherapeutic Group
Drugs for obstructive airway diseases
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| umeclidinium bromide | N/A | umeclidinium bromide |
EMA Name
Rolufta Ellipta (previously Rolufta)
Medicine Name
Rolufta Ellipta (previously Rolufta)
Aliases
N/ANo risk management plan link.
